AFT Pharmaceuticals Expands into China with Crystaderm
Company Announcements

AFT Pharmaceuticals Expands into China with Crystaderm

AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.

AFT Pharmaceuticals has struck a deal with Hainan Haiyao Co. Ltd to distribute its innovative skin infection treatment, Crystaderm cream, in China’s vast pharmaceutical market. Crystaderm offers a novel approach to treating skin infections by releasing hydrogen peroxide, providing an alternative to traditional topical antibiotics. Both companies express enthusiasm for the product’s potential in meeting the unmet clinical demand in the Chinese market.

For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App